Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

By  

Acta Neuropsychiatrica, Vol. 25, Iss. 5, 2013-03 ,pp. : 297-306

Cambridge University Press

Access to resources Recommend Favorite

Frequency of Sexual Dysfunction and Other Reproductive Side-effects in Patients with Schizophrenia Treated with Risperidone, Olanzapine, Quetiapine, or Haloperidol: The Results of the EIRE Study

By BOBES J.   GARC A-PORTILLA M. P.   REJAS J.   HERN NDEZ G.   GARCIA-GARCIA M.   RICO-VILLADEMOROS F.   PORRAS A.  

Journal of Sex & Marital Therapy, Vol. 29, Iss. 2, 2003-01 ,pp. : 125-147

Routledge Ltd

Access to resources Recommend Favorite

A Pilot, 15-month, randomised effectiveness trial of Risperidone long-acting injection (RLAI) versus oral atypical antipsychotic agents (AAP) in persons with bipolar disorder

By  

Acta Neuropsychiatrica, Vol. 22, Iss. 2, 2010-04 ,pp. : 68-80

Cambridge University Press

Access to resources Recommend Favorite

Name relearning in elderly patients with schizophrenia: Episodic and temporary, not semantic and permanent

By Kondel Tejinder   Hirsch Steven   Laws Keith  

Cognitive Neuropsychiatry, Vol. 11, Iss. 1, 2006-01 ,pp. : 1-12

Routledge Ltd

Access to resources Recommend Favorite

Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia

By  

International Psychogeriatrics, Vol. 27, Iss. 1, 2015-01 ,pp. : 131-134

Cambridge University Press

Access to resources Recommend Favorite